BCAL Diagnostics (ASX:BDX) Non Operating Income: A$2.56 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BCAL Diagnostics Non Operating Income?

BCAL Diagnostics ASX:BDX +19.23% Non Operating Income is A$2.56 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. BCAL Diagnostics's Non Operating Income for the six months ended in Dec. 2025 was A$1.21 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was A$2.56 Mil.

BCAL Diagnostics Non Operating Income Related Terms

BCAL Diagnostics Non Operating Income Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics Non Operating Income Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Non Operating Income
0.70 2.79 3.05 2.63

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.86 1.19 1.28 1.35 1.21

BCAL Diagnostics Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$2.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of A$2.56 Mil mean?
BCAL Diagnostics (ASX:BDX) has a Non Operating Income of A$2.56 Mil as of Dec. 2025. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on BCAL Diagnostics and its competitors.
Is BCAL Diagnostics' Non Operating Income too high?
BCAL Diagnostics' current Non Operating Income is A$2.56 Mil.
How does BCAL Diagnostics' Non Operating Income compare to TMO and DHR?
BCAL Diagnostics' Non Operating Income of A$2.56 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Medical Diagnostics & Research company?
A good Non Operating Income depends on the Medical Diagnostics & Research industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on BCAL Diagnostics and its competitors. BCAL Diagnostics's current Non Operating Income is A$2.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current Non Operating Income of A$2.56 Mil. The current Non Operating Income is A$2.56 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current Non Operating Income is A$2.56 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.